Explain this page
Arphra AIPlain-English read on Revolution Medicines, Inc.’s valuationM&A activity
1DBWhole-company transactions where RVMD is acquirer or target.
| Date | Role | Counterparty | Filing |
|---|---|---|---|
| Sep 13, 2023 | Acquirer | EQRx, Inc. | SEC → |
Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.